Correlation Between Cognizant Technology and Neurocrine Biosciences
Can any of the company-specific risk be diversified away by investing in both Cognizant Technology and Neurocrine Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cognizant Technology and Neurocrine Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cognizant Technology Solutions and Neurocrine Biosciences, you can compare the effects of market volatilities on Cognizant Technology and Neurocrine Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cognizant Technology with a short position of Neurocrine Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cognizant Technology and Neurocrine Biosciences.
Diversification Opportunities for Cognizant Technology and Neurocrine Biosciences
0.42 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Cognizant and Neurocrine is 0.42. Overlapping area represents the amount of risk that can be diversified away by holding Cognizant Technology Solutions and Neurocrine Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neurocrine Biosciences and Cognizant Technology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cognizant Technology Solutions are associated (or correlated) with Neurocrine Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neurocrine Biosciences has no effect on the direction of Cognizant Technology i.e., Cognizant Technology and Neurocrine Biosciences go up and down completely randomly.
Pair Corralation between Cognizant Technology and Neurocrine Biosciences
Assuming the 90 days trading horizon Cognizant Technology is expected to generate 36.85 times less return on investment than Neurocrine Biosciences. But when comparing it to its historical volatility, Cognizant Technology Solutions is 17.42 times less risky than Neurocrine Biosciences. It trades about 0.22 of its potential returns per unit of risk. Neurocrine Biosciences is currently generating about 0.47 of returns per unit of risk over similar time horizon. If you would invest 3,490 in Neurocrine Biosciences on September 5, 2024 and sell it today you would earn a total of 374.00 from holding Neurocrine Biosciences or generate 10.72% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Cognizant Technology Solutions vs. Neurocrine Biosciences
Performance |
| Timeline |
| Cognizant Technology |
| Neurocrine Biosciences |
Cognizant Technology and Neurocrine Biosciences Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cognizant Technology and Neurocrine Biosciences
The main advantage of trading using opposite Cognizant Technology and Neurocrine Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cognizant Technology position performs unexpectedly, Neurocrine Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neurocrine Biosciences will offset losses from the drop in Neurocrine Biosciences' long position.The idea behind Cognizant Technology Solutions and Neurocrine Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| Neurocrine Biosciences vs. Hospital Mater Dei | Neurocrine Biosciences vs. Take Two Interactive Software | Neurocrine Biosciences vs. Southwest Airlines Co | Neurocrine Biosciences vs. American Airlines Group |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Other Complementary Tools
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |